Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Study results from Shanghai Jiao Tong University provide new insights into Alzheimer disease
May 18th, 2008
"(1) Nicotinic acetylcholine receptors in central nervous system are thought to be new targets for Alzheimer's disease. However, the most involved nicotinic receptor subtype in Alzheimer's disease is unclear. alpha 4 beta 2 receptor is the most widely spread subtype in brain, involving in several important aspects of cognitive and other functions," researchers in Shanghai, People's Republic of China report. "We constructed cell line by transfecting human amyloid precursor protein (695) gene into SH-EP1 cells which have been transfected with human nicotinic receptor alpha 4 subunit and beta 2 subunit gene, to observe effects of alpha 4 beta 2 receptors activation on...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
